Atlas Trials

Recurrent Cutaneous Melanoma

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Cutaneous Melanoma

RecordFirmDate
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer (NCT05098210)Fred Hutchinson Cancer Center2022-06-09
A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma (NCT04708418)National Cancer Institute (NCI)2021-10-15
Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement (NCT04221438)ECOG-ACRIN Cancer Research Group2021-09-22
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors (NCT03420963)M.D. Anderson Cancer Center2018-08-31
Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma (NCT02581930)National Cancer Institute (NCI)2016-12-16
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery (NCT02506153)National Cancer Institute (NCI)2015-11-10

Track Recurrent Cutaneous Melanoma automatically

Every clearance here is in the API, with alerts when new ones post.